bioRxiv Science⌕ Search

Biology subjects

Riccio, A.

Publications and source records attributed to Riccio, A..

13 recordsLinked to original sources

Quantitative spatial connectomics of liver reveals a partially exposed sympathetic network that integrates multiple cell types across the portal tract

Peripheral tissues are innervated by sparse axonal networks that regulate homeostasis, regeneration and disease, yet their three-dimensional architecture and cellular targets remain largely unknown. Here, we present an EM workflow for quantitative 3D spatial connectomics to define these networks. We identify the mouse liver connectome as a meshwork, rather than a tree-like structure, of mainly sympathetic axons, in which partial Schwann cell coverage is associated with exposed varicosities along the length of individual axons with large regions of the network devoid of glial coverage. Axon tracing identified axonal terminals throughout the network, but the vast majority of cellular contacts involved exposed 'en passant' varicosities. While both terminals and varicosities innervated the vasculature, most synaptic-like contacts involved hepatocytes, fibroblasts, macrophages, and the stem-cell niche, with all individual axons contacting different cell types along their length, highlighting the network nature of liver innervation, the potential for co-ordinating tissue function and demonstrating the power of this approach for decoding connectivity in peripheral tissues.

neuroscience↗

m6A methylation regulates RNA axonal localisation and translation in developing neurons

Methylation on adenosine N6 (m6A) is an abundant post-transcriptional modification of the RNA that regulates almost the entire lifespan of RNA transcripts, from splicing and nuclear export to RNA stability and translation. Peripheral localisation of RNA is an event common to most cells and especially relevant in neurons where transcripts are trafficked to subcellular compartments to promote growth and differentiation in axons, and synaptic functions in dendrites. Here we show that in developing sympathetic neurons, m6A modification regulates RNA transport and local translation in axons. Critically, Nerve Growth Factor (NGF), a neurotrophin essential for axon growth and neuronal survival, promotes the axonal localisation of methylated transcripts and inhibits protein synthesis of trafficking RNAs, preventing premature protein expression. Noticeably, the translation of the bifunctional mRNA Trp53Inp2 depended on the methylation of the 3UTR, further supporting the key role of m6A modification in determining mRNA fate. Mutation of Trp53Inp2 m6A elements resulted in ectopic translation, defects of axon extension and neuronal death. Together, these data show that m6A is critical for RNA peripheral localisation and spatial regulation of protein expression.

neuroscience↗

Antiviral activity of the non-steroidal anti-inflammatory drug indomethacin against Respiratory Syncytial Virus

Human respiratory syncytial virus (RSV) is a ubiquitous pathogen belonging to the Pneumoviridae family. The enveloped virion contains a single-stranded, negative-sense RNA genome comprising 10 genes encoding 11 proteins. Infection is critically dependent on the RSV fusion (F)-protein, which mediates fusion between the viral envelope and host cells, as well as fusion of infected cells with adjacent cells, resulting in syncytium formation. RSV is the leading cause of hospitalization in children younger than 5-years of age with acute respiratory infections, posing a high risk of bronchiolitis and severe pneumonia particularly in infants under 6-months of age. RSV is also recognized to cause a substantial health burden in older adults. Virus-triggered exacerbated inflammation is associated with severe RSV disease outcomes. Although several F-targeting vaccines and monoclonal antibodies are now available for prevention of RSV disease in infants and older adults in several countries, there is no effective specific drug treatment for RSV. Herein we show that the non-steroidal anti-inflammatory drug indomethacin has a remarkable antiviral activity against RSV, causing a decrease in infectious virus production in different types of human respiratory cells at low micromolar concentrations. Whereas the mechanisms underlying the antiviral activity against RSV remain to be elucidated, we found that indomethacin does not affect RSV adsorption or entry into host cells, but acts at postentry level interfering with F-protein expression. The results suggest that indomethacin, possessing both anti-inflammatory properties and a direct antiviral activity against RSV, may represent an useful tool for the treatment of respiratory syncytial virus infections.

microbiology↗

Identification of genetic and non-genetic modifiers of genomic imprinting through whole genome screening in humans

Genomic imprinting is required for normal development, and abnormal methylation of differentially methylated regions (iDMRs) controlling the parent of origin-dependent expression of the imprinted genes has been found in constitutional disorders affecting growth, metabolism, neurobehavior, and in cancer. In most of these cases the cause of the imprinting abnormalities is unknown. Also, these studies have generally been performed on a limited number of CpGs, and a systematic investigation of iDMR methylation in the general population is lacking. By analysing the iDMRs in a large number of peripheral blood DNA methylation array datasets of unaffected individuals and patients with rare disorders, we determined the most common iDMR methylation profiles and identified many genetic and non-genetic factors contributing to their variability. We found that methylation variability is not homogeneous within the iDMRs and that the CpGs closer to the ZFP57 binding sites are less susceptible to methylation changes. We demonstrated the methylation polymorphism of three iDMRs and the atypical behaviour of several others, and reported the association of 25 disease- and 47 non-disease-complex traits, including blood cell type composition, as well as 15 mendelian or chromosomal disorders, with iDMR methylation changes in blood DNA. These findings identify several genetic and non-genetic factors associated with genomic imprinting maintenance in humans, which may have a role in the aetiology of the diseases associated with imprinting abnormalities and have clear implications in molecular diagnostics.

genetics↗

A maternal-effect Padi6 variant results in abnormal nuclear localization of DNMT1 and failure of epigenetic reprogramming and zygotic genome activation in mouse embryos

PADI6 belongs to the multi-protein sub-cortical maternal complex (SCMC) that is present specifically in mammalian oocytes and early embryos. Maternal inactivation of SCMC genes generally results in early embryo lethality. In humans, variants in a subset of SCMC genes have been found in the healthy mothers of children affected by genomic imprinting disorders and characterized by multi-locus imprinting disturbances (MLID). However, how the SCMC controls the DNA methylation required to regulate imprinting remains poorly defined. To address this issue, we generated a mouse line carrying a Padi6 missense variant that had been identified in the mother of two sisters affected by Beckwith-Wiedemann syndrome and MLID. We found that if homozygous in female mice this variant resulted in interruption of embryo development at the 2-cell stage. Single-cell DNA methylation and RNA analyses demonstrated genomic hypermethylation, down-regulation of zygotic genome activation (ZGA) genes and up-regulation of maternal decay genes in 2-cell embryos from homozygous females. In addition, immunofluorescence analysis showed abnormal localization of DNMT1 and UHRF1 in mutant oocytes and zygotes. Taken together, this study demonstrates that PADI6 controls the subcellular localization of DNMT1 that is necessary for pre-implantation epigenetic reprogramming and ZGA.

genomics↗

Human coronaviruses activate and hijack the proteostasis guardian HSF1 to enhance viral replication

Organisms respond to proteotoxic stress by activating a cellular defense mechanism, known as the heat shock response (HSR), that triggers the expression of cytoprotective heat shock proteins (HSP) to counteract the damaging effects of proteostasis disruption. The HSR is regulated by a family of transcription factors (heat shock factors, HSFs); among six human HSFs, HSF1 acts as a proteostasis guardian regulating acute and severe stress-driven transcriptional responses. Seasonal coronaviruses HCoV-229E, HCoV-NL63, HCoV-OC43 and HCoV-HKU1 (sHCoV) are globally circulating in the human population. Although sHCoV generally cause only mild upper respiratory diseases in immunocompetent hosts, severe complications may occur in specific populations. There is no effective treatment for sHCoV infections, also due to the limited knowledge on sHCoV biology. We now show that both Alpha- and Beta-sHCoV are potent inducers of HSF1, selectively promoting HSF1 phosphorylation at serine-326 residue and nuclear translocation, and triggering a powerful HSF1-driven transcriptional response in infected cells at late stages of infection. Despite the coronavirus-mediated shut-down of the host cell translational machinery, high levels of selected canonical and non-canonical HSF1-target genes products, including HSP70, HSPA6 and the zinc-finger AN1-type domain-2a gene/AIRAP, were found in HCoV-infected cells. Interestingly, silencing experiments demonstrate that HSR activation does not merely reflect a cellular defense response to viral infection, but that sHCoV activate and hijack the HSF1-pathway for their own gain. Notably, nuclear HSF1 pools depletion via Direct-Targeted HSF1 inhibitor (DTHIB) treatment was highly effective in hindering sHCoV replication in lung cells. Altogether the results open new scenarios for the search of innovative antiviral strategies in the treatment of coronavirus infections.

microbiology↗

The RNA Binding proteome of axonal mRNAs in sympathetic neurons

BackgroundNeurons are morphologically complex cells that rely on the compartmentalization of protein expression to develop and maintain their cytoarchitecture. Targeting of RNA transcripts to axons is one of the mechanisms that allows rapid local translation of proteins in response to extracellular signals. 3 untranslated regions (UTRs) of mRNA are non-coding sequences that play a critical role in determining transcript localisation and translation by interacting with specific RNA binding proteins (RBPs). However, how 3UTRs contribute to mRNA metabolism and the nature of RBP complexes responsible for these functions remain elusive. ResultsWe performed 3 end sequencing of RNA isolated from axons and cell bodies of sympathetic neurons exposed to either Nerve Growth factor (NGF) or Neurotrophin 3 (NT3). NGF and NT3 are growth factors essential for sympathetic neuron development that act through distinct signalling mechanisms. Whereas NT3 is thought to act only locally, NGF signals back from axons to the cell bodies. We discovered that both NGF and NT3 affect transcription and alternative polyadenylation and induce the localisation of specific 3UTR isoforms to axons. The finding that many transcripts with short 3UTR were detected only in axons suggest that these may undergo local post-transcriptional remodelling. The integration of our data with CLIP-sequencing data revealed that long 3UTR isoforms associate with RBP complexes in the nucleus, and once in axons, regulate cytoplasmic 3 UTR isoform cleavage into shorter isoform. ConclusionsOur findings shed new light on the complex interplay between nuclear polyadenylation, mRNA localisation and local 3UTR remodelling in developing neurons. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=106 SRC="FIGDIR/small/517728v1_ufig1.gif" ALT="Figure 1"> View larger version (36K): org.highwire.dtl.DTLVardef@17196eforg.highwire.dtl.DTLVardef@6c26adorg.highwire.dtl.DTLVardef@5f335borg.highwire.dtl.DTLVardef@24a6d6_HPS_FORMAT_FIGEXP M_FIG C_FIG

neuroscience↗

Nitazoxanide is a potent inhibitor of human seasonal coronaviruses acting at postentry level: effect on viral spike glycoprotein

Coronaviridae is recognized as one of the most rapidly evolving virus family as a consequence of the high genomic nucleotide substitution rates and recombination. The family comprises a large number of enveloped, positive-sense single-stranded RNA viruses, causing an array of diseases of varying severity in animals and humans. To date, seven human coronaviruses (HCoV) have been identified, namely HCoV-229E, HCoV-NL63, HCoV-OC43 and HCoV-HKU1, which are globally circulating in the human population (seasonal HCoV, sHCoV), and the highly pathogenic SARS-CoV, MERS-CoV and SARS-CoV-2. Seasonal HCoV are estimated to contribute to 15-30% of common cold cases in humans; although diseases are generally self-limiting, sHCoV can sometimes cause severe lower respiratory infections, as well as enteric and neurological diseases. No specific treatment is presently available for sHCoV infections. Herein we show that the anti-infective drug nitazoxanide has a potent antiviral activity against three human endemic coronaviruses, the Alpha-coronaviruses HCoV-229E and HCoV-NL63, and the Beta-coronavirus HCoV-OC43 in cell culture with IC50 ranging between 0.05 and 0.15 g/ml and high selectivity indexes. We found that nitazoxanide does not affect HCoV adsorption, entry or uncoating, but acts at postentry level and interferes with the spike glycoprotein maturation, hampering its terminal glycosylation at an endoglycosidase H-sensitive stage. Altogether the results indicate that nitazoxanide, due to its broad-spectrum anti-coronavirus activity, may represent a readily available useful tool in the treatment of seasonal coronavirus infections.

microbiology↗

Spike mutation resilient scFv76 antibody counteracts SARS-CoV-2 lung damage upon aerosol delivery

Uneven worldwide vaccination coverage against SARS-CoV-2 and emergence of variants escaping immunity call for broadly-effective and easily-deployable therapeutics. We previously described the human single-chain scFv76 antibody, which recognizes SARS-CoV-2 Alfa, Beta, Gamma and Delta variants. We now show that scFv76 also neutralizes infectivity and fusogenic activity of Omicron BA.1 and BA.2 variants. Cryo-EM analysis reveals that scFv76 binds to a well-conserved SARS-CoV-2 spike epitope, providing the structural basis for its broad-spectrum activity. Moreover, we demonstrate that nebulized scFv76 exhibits therapeutic efficacy in a severe hACE2 transgenic mouse model of COVID-19 pneumonia, as shown by body weight and pulmonary viral load data. Counteraction of infection correlates with the inhibition of lung inflammation observed by histopathology and expression of inflammatory cytokines and chemokines. Biomarkers of pulmonary endothelial damage were also significantly reduced in scFv76-treated mice. Altogether the results support the use of nebulized scFv76 for COVID-19 induced by any SARS-CoV-2 variants emerged so far.

microbiology↗

A novel enhancer that regulates Bdnf expression in developing neurons

Brain derived neurotrophic factor (BDNF) is a critical secreted peptide that promotes neuronal differentiation and survival, and its downregulation is implicated in many neurological disorders. Here, we investigated the regulation of the mouse Bdnf gene in cortical neurons and identified a novel enhancer that promotes the expression of many Bdnf transcript variants during differentiation, increasing total Bdnf mRNA levels. Enhancer activity contributes to Bdnf-mediated effects on neuronal clustering and activity-dependent dendritogenesis. During Bdnf activation, enhancer-promoter contacts increase, and the region moves away from the repressive nuclear periphery. Our findings suggest that changes in nuclear structure may contribute to the expression of essential growth factors during neuronal development.

molecular biology↗

Human single-chain antibodies neutralize SARS-CoV-2 variants by engaging an essential epitope of the spike: a new weapon against COVID-19

As of October 2021, coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remains a global emergency, and novel therapeutics are urgently needed. Here we describe human single chain variable fragment (scFv) antibodies (76clAbs) that block an epitope of the SARS-CoV-2 spike protein essential for ACE2-mediated entry into cells. 76clAbs neutralize the delta variant and other variants being monitored (VBMs) and inhibit spike-mediated pulmonary cell-cell fusion, a critical feature of COVID-19 pathology. In two independent animal models, intranasal administration counteracted the infection. Due to high efficiency, remarkable stability, resilience to nebulization and low production cost, 76clAbs may become a relevant tool for rapid, self-administrable early intervention in SARS-CoV-2-infected subjects independently of their immune status.

bioengineering↗

Impairment of SARS-CoV-2 spike glycoprotein maturation and fusion activity by the broad-spectrum anti-infective drug nitazoxanide

SARS-CoV-2, the causative agent of COVID-19, has caused an unprecedented global health crisis. The SARS-CoV-2 spike, a surface-anchored trimeric class-I fusion-glycoprotein essential for viral entry, represents a key target for developing vaccines and therapeutics capable of blocking virus invasion. The emergence of SARS-CoV-2 spike-variants that facilitate virus spread and may affect vaccine efficacy highlights the need to identify novel antiviral strategies for COVID-19 therapy. Here we demonstrate that nitazoxanide, an antiprotozoal agent with recognized broad-spectrum antiviral activity, interferes with SARS-CoV-2 spike biogenesis, hampering its maturation at an endoglycosidase H-sensitive stage. Engineering multiple SARS-CoV-2 variant-pseudoviruses and utilizing quantitative cell-cell fusion assays, we show that nitazoxanide-induced spike modifications hinder progeny virion infectivity as well as spike-driven pulmonary cell-cell fusion, a critical feature of COVID-19 pathology. Nitazoxanide, being equally effective against the ancestral SARS-CoV-2 Wuhan-spike and different emerging variants, including the Delta variant of concern, may represent a useful tool in the fight against COVID-19 infections.

microbiology↗

3’UTR Remodelling of Axonal Transcripts in Sympathetic Neurons

The 3 untranslated regions (3UTRs) of messenger RNAs (mRNA) are non-coding sequences that regulate several aspects of mRNA metabolism, including intracellular localisation and translation. Here, we show that in sympathetic neuron axons, the 3UTRs of many transcripts undergo cleavage, generating both translatable isoforms expressing a shorter 3UTR, and 3UTR fragments. 3end RNA sequencing indicated that 3UTR cleavage is a potentially widespread event in axons, which is mediated by a protein complex containing the endonuclease Ago2 and the RNA binding protein HuD. Analysis of the Inositol monophosphatase 1 (Impa1) mRNA revealed that a stem loop structure within the 3UTR is necessary for Ago2 cleavage. Thus, remodeling of the 3UTR provides an alternative mechanism that simultaneously regulates local protein synthesis and generates a new class of 3UTR RNAs with yet unknown functions.

neuroscience↗